Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
An Open-Label Multidose Psilocybin Intervention for Obsessive-Compulsive Disorder.medRxiv · 2026-10-05Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophrenia.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-10-01Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in ratsPharmacology Biochemistry and Behavior · 2026-10-01Psilocybin and ayahuasca in treatment-resistant depression: clinical evidence, methodological constraints and ethical challenges: a narrative reviewFrontiers in psychiatry · 2026-09-30Reply to 'Methodological concerns and interpretative limitations of assessing subjective effects of ketamine'.Npj mental health research · 2026-09-22A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study to Identify a Subperceptual Dose of Psilocybin in Healthy AdultsPharmaceuticals · 2026-09-21Exploring the Therapeutic Potential of Psilocybin: A Comprehensive Review of Clinical Trial Evidence and Implications for Rescheduling.Mini reviews in medicinal chemistry · 2026-09-18Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01Balancing safety and access in Oregon's psilocybin services.The International journal on drug policy · 2026-09-01A dominant frontoparietal beta oscillatory brain state in the days after psilocybin and 5-MeO-DMTbioRxiv · 2026-08-27Beyond head-twitch response: Acute psilocybin affects spontaneous behaviors in rats in a dose-dependent manner.Journal of psychopharmacology (Oxford, England) · 2026-08-25Psychedelics align brain activity with context.Nature · 2026-08-19A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.The journal of pain · 2026-08-07Impact of Psilocybin on Motor Function in Healthy Participants: A Phase 1, Randomised, Triple-Blind, Dose-Finding Study.CNS drugs · 2026-08-07One Dose of Psilocybin May Alter Brain StructurePsychiatric News · 2026-08-01A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-07-23The "dark magic mushroom" co-produces amatoxins and psilocybin.bioRxiv: the preprint server for biology · 2026-07-22A randomized, double-blind, placebo-controlled single-ascending-dose study to identify a non-hallucinogenic dose of psilocybin in healthy adultsmedRxiv · 2026-07-19Unmixing the psychedelic connectome: Brain network traits of psilocybinNetwork Neuroscience · 2026-07-02Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-07-01Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.Schizophrenia research · 2026-06-01Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment-Resistant Depression: A Qualitative Study.Brain and behavior · 2026-06-01Psychedelic Therapy and the Role of Music: A Scoping Review of Quantitative Evidence on Subjective and Objective Outcomes.Brain and behavior · 2026-06-01Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in ratsProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-06-01Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-28Retail Availability of Intoxicating Cannabis and Mushroom Products Across Eleven U.S. Cities: Sales Persist Despite Prohibitions.Journal of studies on alcohol and drugs · 2026-05-28Group Psilocybin-Assisted Therapy for Post-Traumatic Stress DisorderClinicalTrials.gov · 2026-05-22Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms.Journal of affective disorders · 2026-05-01Characterizing psilocybin’s effects on nociception and thermoregulation in preclinical pain modelsStanford Digital Repository · 2026-04-30Psilocybin use among Basotho healers and non-healers in southern AfricaOSF Preprints · 2026-04-23Psilocybin’s Kinematic Effect on Manual DexterityResearch Square · 2026-04-15Psilocybin Production With Genetically Modified Aspergillus nidulans Under Pressurized Conditions.Biotechnology and bioengineering · 2026-04-01An international mega-analysis of psychedelic drug effects on brain circuit function.Nature medicine · 2026-04-01The astrocytes in the prefrontal cortex contribute to the rapid antidepressant-like effects of psilocybin in the chronic restraint stress mouse modelProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-04-01Psychedelics in functional disorders: A scoping review.Progress in neuro-psychopharmacology & biological psychiatry · 2026-03-20Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials.ACS pharmacology & translational science · 2026-03-13Age moderates the relationship between psychedelics use and mental health in naturalistic settingsResearch Square · 2026-03-10Examining the Safety and Clinical Efficacy of Psilocybin Therapy for Veterans With PTSD: An Open-Label Proof-of-Concept TrialClinicalTrials.gov · 2026-03-04Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applicationsProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-03-01Psychedelic medicine: mechanisms, evidence, and translation to practice.BMJ (Clinical research ed.) · 2026-02-23Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER: a Pilot StudyClinicalTrials.gov · 2026-02-05Patient perspectives on research gaps in cluster headache.Headache · 2026-02-01Participant Experiences of Therapeutic Touch in Psilocybin-Assisted Therapy.Brain and behavior · 2026-02-01Psychedelic- and Substance-Assisted Therapies in Global Mental Health: Bridging Cultures, Evidence, and Access.Brain and behavior · 2026-02-01Bioactive compounds from Psilocybe cubensis mycelial cultures with transient anxiolytic effects in mice.Journal of physiology and pharmacology: an official journal of the Polish Physiological Society · 2026-02-01The one that abstained: Psilocybe fuscofulva genome suggests two recent origins of the psilocybin gene cluster in PsilocybebioRxiv · 2026-01-02Dynamic response of intrinsic connectivity networks to low-dose psilocybin during face matching in autistic adultsNeuroscience Applied · 2026-01-01Building standards of psychedelic care: Qualitative examination of expert perspectives on safety, inclusion, and accountability.The International journal on drug policy · 2026-01-01A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy ParticipantsmedRxiv · 2025-12-23Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.Progress in neuro-psychopharmacology & biological psychiatry · 2025-12-20Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial.Progress in neuro-psychopharmacology & biological psychiatry · 2025-12-20Safety, feasibility, and tolerability of psilocybin in older adults with amnestic MCI: Preliminary data from a SV2a PET imaging studyAlzheimer's & dementia: the journal of the Alzheimer's Association · 2025-12-01Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions.Psychedelic medicine (New Rochelle, N.Y.) · 2025-12-01Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot study.Acta neuropsychiatrica · 2025-11-04Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.EClinicalMedicine · 2025-11-01Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial.Pilot and feasibility studies · 2025-10-28Analysis of Serotonin in Caenorhabditis Elegans Subjected to Micro-Dosing with Psilocybin| Iris PublishersInsights in Chemistry and Biochemistry · 2025-10-15Psilocybin-assisted psychotherapy in adults with depression - A literature review.Progress in neuro-psychopharmacology & biological psychiatry · 2025-10-02Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior.Progress in neuro-psychopharmacology & biological psychiatry · 2025-10-02Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathwayNaunyn-Schmiedeberg's Archives of Pharmacology · 2025-10-01Active Constituents of Psilocybin Mushroom Edibles.JAMA network open · 2025-09-02Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.Progress in neuro-psychopharmacology & biological psychiatry · 2025-08-30An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.Progress in neuro-psychopharmacology & biological psychiatry · 2025-08-30Context-dependent structurally informed effective connectivity under psilocybinbioRxiv · 2025-08-22Psychedelics and the Serotonin Hypothesis of Eating Disorders.Brain sciences · 2025-08-21426. THE MGLUR2/3 ANTAGONIST ENHANCES THE BEHAVIORAL AND CELLULAR ANTIDEPRESSANT-LIKE EFFECTS OF PSILOCYBIN AND SCOPOLAMINEThe international journal of neuropsychopharmacology · 2025-08-01Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial.Addiction (Abingdon, England) · 2025-07-24Behavioural and pharmacological evaluation of the psilocybin analogue baeocystin in Wistar rats.Progress in neuro-psychopharmacology & biological psychiatry · 2025-07-13Clinical Psychedelic Therapy Research Involving Adolescents: Protocol for a Scoping Review of Intervention StudiesWellcome Open Res · 2025-07-08Exploring Jordanian Physicians' and Medical Students' Perspectives on Ketamine and Psychedelic-Assisted Therapies: An Insight from the Middle East.Journal of psychoactive drugs · 2025-07-06Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.Psychopharmacology · 2025-07-015-HT receptors: Pharmacology and functional selectivity.Pharmacological reviews · 2025-07-01Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings.Brain and behavior · 2025-07-01Deconstructing Psychedelic Phenomenology: A Thematic Analysis of Discrete Phases of the Psychedelic ExperienceBrain and Behavior · 2025-06-30Psilocybin Modulates TPJ Effective Connectivity during Out-of-Body ExperiencesmedRxiv · 2025-06-25Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use.British journal of pain · 2025-06-01The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review.Brain sciences · 2025-05-26ALSUntangled #77: Psilocybin.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025-05-01Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-05-01PsiConnect: A Multimodal Neuroimaging Study of Psilocybin-Induced Changes in Brain and BehaviourbioRxiv · 2025-04-14Psilocybin as a Tool in the Management of Palliative Care: An Historical, Pharmacological, and Clinical ApproachPreprints.org · 2025-04-10Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review.Progress in neuro-psychopharmacology & biological psychiatry · 2025-04-02The effect of low-dose psilocybin on brain neurotransmission and rat behavior.Progress in neuro-psychopharmacology & biological psychiatry · 2025-04-02Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis.Progress in neuro-psychopharmacology & biological psychiatry · 2025-04-02Psilocybin has a narrow therapeutic window as an antidepressant treatment.Progress in neuro-psychopharmacology & biological psychiatry · 2025-04-02Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine PathwaysPharmacology Research & Perspectives · 2025-04-01Psilocybin-Assisted Therapy May Enhance Conservation Values in Patients with Alcohol Use Disorder.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy.Progress in neuro-psychopharmacology & biological psychiatry · 2025-01-10Psychedelic-related deaths in England, Wales and Northern Ireland (1997-2022).Progress in neuro-psychopharmacology & biological psychiatry · 2025-01-10Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats.Progress in neuro-psychopharmacology & biological psychiatry · 2025-01-10Cell-type specific transcriptional modulation by psilocybin induces sustained plasticity in mouse medial prefrontal cortexbioRxiv · 2025-01-08Unveiling the Psychedelic Journey: An Appraisal of Psilocybin as a Profound Antidepressant Therapy.Molecular biotechnology · 2025-01-01Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study.Journal of psychoactive drugs · 2025-01-01Informed Consent Documents from Psychedelic Clinical Trials: A Descriptive Ethical Analysis.AJOB empirical bioethics · 2025-01-01Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic Use.Journal of psychoactive drugs · 2025-01-01The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences.Therapeutic advances in psychopharmacology · 2025-01-01Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.JAMA psychiatry · 2024-12-01The molecular structure, vibrational spectra, solvation effect, non-covalent interactions investigations of psilocinSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2024-11-01Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcome.Npj mental health research · 2024-10-06Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms.Molecular psychiatry · 2024-10-01Psilocybin for clinical indications: A scoping review.Journal of psychopharmacology (Oxford, England) · 2024-10-01Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.EClinicalMedicine · 2024-10-01At the Forefront: Social Workers' Role in Psilocybin Treatment for Depression and Substance Misuse.Social work · 2024-06-21Psilocybin in Bipolar II Study Provides Preliminary Data on Safety.JAMA psychiatry · 2024-06-01Impact of Psilocybin on Peripheral Cytokine Production.Psychedelic medicine (New Rochelle, N.Y.) · 2024-06-01Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial.Trials · 2024-05-21Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.Journal of psychopharmacology (Oxford, England) · 2024-05-01Psychedelics and the 'inner healer': Myth or mechanism?Journal of psychopharmacology (Oxford, England) · 2024-05-01Genetic regulation of L-tryptophan metabolism in Psilocybe mexicana supports psilocybin biosynthesis.Fungal biology and biotechnology · 2024-04-25Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for DepressionPsychoactives · 2024-04-15Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways.Ageing research reviews · 2024-04-01American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A7-Year Follow-Up Survey.Psychedelic medicine (New Rochelle, N.Y.) · 2024-03-01Preadministration of Lorazepam Reduces Efficacy and Longevity of Antidepressant-Like Effect from a Psychedelic.Psychedelic medicine (New Rochelle, N.Y.) · 2024-03-01Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study.Scientific reports · 2024-02-07Established sensitization of ethanol-induced locomotor activity is not reversed by psilocybin or the 5-HT receptor agonist TCB-2 in male DBA/2J mice.Pharmacology, biochemistry, and behavior · 2024-02-01Exploring the molecular basis of treatment-resistant depression: Discoveries from a rat model and psilocybin therapyNeuroscience Applied · 2024-01-01The psychedelic effects of cannabis: A review of the literature.Journal of psychopharmacology (Oxford, England) · 2024-01-01Psilocybin Without Psychotherapy: A Cart Without a Horse?The American journal of psychiatry · 2024-01-01Older adults in psychedelic-assisted therapy trials: A systematic review.Journal of psychopharmacology (Oxford, England) · 2024-01-01Valuing the Acute Subjective Experience.Perspectives in biology and medicine · 2024-01-01Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders.Journal of addiction psychiatry · 2024-01-01Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey.Frontiers in psychiatry · 2024-01-01Strong Bipartisan Support for Controlled Psilocybin Use as Treatment or Enhancement in a Representative Sample of US Americans: Need for Caution in Public Policy Persists.AJOB neuroscience · 2024-01-01Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy Participants.Psychiatric research and clinical practice · 2024-01-01Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.Journal of psychoactive drugs · 2024-01-01Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and OverviewPsyArXiv · 2023-12-26Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. PsilocybinPsyArXiv · 2023-12-26Psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanismsbioRxiv · 2023-12-13The entropic heart: Tracking the psychedelic state via heart rate dynamicsbioRxiv · 2023-11-09Managing expectations with psychedelic microdosingnpj Mental Health Research · 2023-11-08An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).Pilot and feasibility studies · 2023-10-05Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2023-10-01Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.JAMA · 2023-09-05Psychedelics, With a Focus on Psilocybin: Issues for the Clinician.Journal of psychiatric practice · 2023-09-01Applying Key Lessons from the Hospice and Palliative Care Movement to Inform Psychedelic-Assisted Therapy.Psychedelic medicine (New Rochelle, N.Y.) · 2023-09-01Psilocybin desynchronizes brain networks.medRxiv: the preprint server for health sciences · 2023-08-24Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022.Palliative & supportive care · 2023-08-01"Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli".Biotechnology and bioengineering · 2023-08-01A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocolEuropean psychiatry: the journal of the Association of European Psychiatrists · 2023-07-19Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD)ClinicalTrials.gov · 2023-07-06Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use.Journal of psychopharmacology (Oxford, England) · 2023-07-01Psychedelics, Meaningfulness, and the "Proper Scope" of Medicine: Continuing the Conversation.Cambridge quarterly of healthcare ethics: CQ: the international journal of healthcare ethics committees · 2023-06-27In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.Science advances · 2023-06-16Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal StudyPsyArXiv · 2023-06-09National Institutes of Health psilocybin research speaker series: State of the science, regulatory and policy landscape, research gaps, and opportunities.Neuropharmacology · 2023-06-01The evolution and ecology of psilocybin in nature.Fungal genetics and biology: FG & B · 2023-06-01High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybinbioRxiv · 2023-04-14A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.Psychedelic medicine (New Rochelle, N.Y.) · 2023-03-01Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway.Fungal genetics and biology: FG & B · 2023-03-01Matrix-assisted laser-desorption/ionization-mass spectrometric imaging of psilocybin and its analogues in psychedelic mushrooms using a cesium chloride-coated target plate.Analytical and bioanalytical chemistry · 2023-02-01Case report: Psychedelic-induced seizures captured by intracranial electrocorticography.Frontiers in neurology · 2023-01-01Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03Serotonergic antidepressant use is associated with weaker psilocybin effectsPsyArXiv · 2022-10-28Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter LandscapebioRxiv · 2022-07-13A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for DepressionPsyArXiv · 2022-07-01Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.Psychopharmacology · 2022-06-01Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in ratsPsychopharmacology · 2022-06-01Counselors’ attitudes toward psychedelics and their use in therapyJournal of Counseling & Development · 2022-03-19Beating pain with psychedelics: Matter over mind?Neuroscience and biobehavioral reviews · 2022-03-01A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.Journal of clinical psychopharmacology · 2022-01-01Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?Frontiers in psychiatry · 2022-01-01Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.The Australian and New Zealand journal of psychiatry · 2021-12-01Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.Science advances · 2021-11-19Spontaneous and deliberate creative cognition during and after psilocybin exposure.Translational psychiatry · 2021-04-08Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans.Journal of psychopharmacology (Oxford, England) · 2021-04-01Use and abuse of dissociative and psychedelic drugs in adolescence.Pharmacology, biochemistry, and behavior · 2021-04-01Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS SurvivorsClinicalTrials.gov · 2021-01-07A Trip Through Employment Law: Protecting Therapeutic Psilocybin Users in the Workplace.Journal of law and health · 2021-01-01Historic psychedelic drug trials and the treatment of anxiety disorders.Depression and anxiety · 2020-12-01Snapshot of narcotic drugs and psychoactive substances in Kuwait: a qualitative analysis of illicit drugs and their associated mortality in Kuwait from 2015 to 2018Research Square · 2020-11-18The use of psychedelics in the treatment of disorders of consciousness. An interview with Olivia Gosseries by Charlotte Martial.Open Repository and Bibliography (University of Liège) · 2020-10-12Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushroomsJournal of Pharmaceutical and Biomedical Analysis · 2020-10-01A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2020-04-01Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.Frontiers in neuroscience · 2020-01-01P.188 Long-term effects of psilocybin on cerebral serotonin 2A receptor levels and personalityEuropean Neuropsychopharmacology · 2019-12-01Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in micebioRxiv · 2019-09-01Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review.Progress in neuro-psychopharmacology & biological psychiatry · 2019-06-08Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study.Human brain mapping · 2019-05-01The Past and Future of Psychedelic Science: An Introduction to This Issue.Journal of psychoactive drugs · 2019-01-01Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humansEuropean Neuropsychopharmacology · 2019-01-01Psychedelic use and intimate partner violence: The role of emotion regulation.Journal of psychopharmacology (Oxford, England) · 2018-07-01Proposal of 5-methoxy-N-methyl-N-isopropyltryptamine consumption biomarkers through identification of in vivo metabolites from mice.Journal of chromatography. A · 2017-07-28Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.Frontiers in psychology · 2017-01-01DNA-based taxonomic identification of basidiospores in hallucinogenic mushrooms cultivated in “grow-kits” seized by the police: LC-UV quali-quantitative determination of psilocybin and psilocinJournal of Pharmaceutical and Biomedical Analysis · 2016-06-01MAGIC MUSHROOM AND ITS EFFECTIVENESSInternational Journal of Pharma and Bio Sciences · 2016-01-01Legal highs: staying on top of the flood of novel psychoactive substances.Therapeutic advances in psychopharmacology · 2015-04-01Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.Therapeutic advances in psychopharmacology · 2014-08-01Serotonergic hyperactivity as a potential factor in developmental, acquired and drug-induced synesthesia.Frontiers in human neuroscience · 2013-01-01Effects of Psilocybe argentipes on marble-burying behavior in mice.Bioscience, biotechnology, and biochemistry · 2009-08-01Analysis of mushroom exposures in Texas requiring hospitalization, 2005-2006.Journal of medical toxicology: official journal of the American College of Medical Toxicology · 2009-06-01Psilocybin-induced stimulus control in the rat.Pharmacology, biochemistry, and behavior · 2007-10-01Psilocybin impairs high-level but not low-level motion perception.Neuroreport · 2004-08-26Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in manJournal of Pharmaceutical and Biomedical Analysis · 2002-09-01Synthesis of a psilocin hapten and a protein-hapten conjugateJournal of Pharmacy and Pharmacology · 2002-09-0111C-radiolabeling of hallucinogenic psilocin, a potential radioligand for studying the role of serotonin receptors in psychotic symptom formationJournal of Labelled Compounds and Radiopharmaceuticals · 1998-07-01Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in manPharmaceutica Acta Helvetiae · 1997-06-01Psilocin analogs. III. Synthesis of 5-methoxy- and 5-hydroxy-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indolesJournal of Heterocyclic Chemistry · 1982-07-01